Stock Events

Stock Events

MoonLake Immunotherapeutics (MLTX) Q2 2026 Earnings

10MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-1.1

-0.98

-0.86

-0.74

Details

Expected EPS

-0.891771

Actual EPS

-0.98

Surprise EPS

-0.09

Surprise Percent

+9.89%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.98 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.